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Background: Little is known on the effects of common calf diseases on mortality and carcass traits in the white
veal industry (special-fed veal), a highly integrated production system, currently criticized for the intensive pro- and
metaphylactic use of antimicrobials. The objective of the present study was to determine the impact of bovine
respiratory disease (BRD), diarrhea, arthritis and otitis on the economically important parameters of mortality, hot
carcass weight (HCW), carcass quality, fat cover and meat color. For this purpose, a prospective study on 3519 white
veal calves, housed in 10 commercial herds, was conducted. Case definitions were based on clinical observation by
the producers and written treatment records were used.
Results: Calves received oral antimicrobial group treatments in the milk during 25.2% of the production time on
average. With an increasing percentage of the production cycle spent on oral antimicrobials, HCW reduced,
whereas the odds for insufficient fat cover or an undesirable red meat color both decreased. Of the calves, 14.8%,
5.3%, 1.5% and 1.6% were individually diagnosed and treated for BRD, diarrhea, arthritis and otitis, respectively.
Overall, 5.7% of the calves died and the mortality risk was higher in the first weeks after arrival. Calves that
experienced one BRD episode showed a 8.2 kg reduction in HCW, a lower fat cover and an increased mortality risk
(hazard ratio (HR) = 5.5), compared to calves which were not individually diagnosed and treated for BRD. With an
increasing number of BRD episodes, these losses increased dramatically. Additionally, calves, which experienced
multiple BRD episodes, were more likely to have poor carcass quality and an undesirable red meat color at
slaughter. Arthritis increased the mortality risk (HR = 3.9), and reduced HCW only when associated with BRD. Otitis
did only increase the mortality risk (HR = 7.0). Diarrhea severely increased the mortality risk (HR = 11.0), reduced
HCW by 9.2 kg on average and decreased carcass quality.
Conclusions: Despite the massive use of group and individual treatments to alleviate the most prevalent health
issues at the fattening period, the effects of BRD, diarrhea, otitis and arthritis on survival and performance are still
considerable, especially in cases of chronic pneumonia with or without arthritis. Controlling calf health by effective
preventive and therapeutic strategies and in particular the prevention of chronic BRD is key for the profitability of
veal operations.
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The white veal industry (special-fed veal) is specialized
in raising, predominantly male, calves of different breeds
on a low iron milk replacer diet to obtain pale veal meat
[1]. European veal production stood at 5.8 million calves
in 2008, with the main producers being France, The
Netherlands and Italy [1]. Also, in the United States
special-fed veal represents a 1 billion dollar industry [2].
Several studies in feedlots and dairy operations have
shown that calf diseases have an important impact on
economic parameters such as mortality, weight gain and
carcass traits and that this impact differs according to
management and treatment strategies [3-13]. Despite the
large production scale and high degree of integration in
the veal industry, little is known on the effects of com-
mon diseases on these economic parameters in contem-
porary, group housed, white veal calves [14-16]. The
most frequent diseases in white veal operations are bo-
vine respiratory disease (BRD), diarrhea, arthritis and
otitis [17]. Whereas most previous studies in different
cattle production systems focused on BRD, there is little
information on the impact of diarrhea, arthritis and oti-
tis in veal or beef production. Available studies on veal
calves either addressed individual housing systems,
which are nowadays prohibited in the European Union,
or only determined short term disease effects related to the
clinical period [14,15,18-21]. In contrast, more recent stud-
ies in other cattle production systems, have shown that sev-
eral of these short term disease effects are less pronounced
or no longer meaningful at slaughter [4,11,22,23]. Contem-
porary veal management relies on the intensive use of oral
pro- and metaphylactic group antimicrobial treatments,
which is highly criticized by the European authorities at
present [24]. A prophylactic treatment is defined as the
treatment of healthy animals to prevent disease from occur-
ring, whereas a metaphylactic treatment implies the simul-
taneous treatment in a shared compartment of clinically
healthy animals and animals that showed clinical symptoms
of the disease [25]. To what extent calves, that still develop
disease under such management, have poorer production
results compared to their pen mates is unknown.
Therefore, the objective of the present study was to deter-
mine the impact of BRD, diarrhea, arthritis and otitis on
mortality and carcass traits (hot carcass weight (HCW),
carcass quality, carcass color and fat cover) in white veal
calves, raised under contemporary management.
Methods
Herds and animals
A prospective cohort study was set up to determine the
impact of veal calf diseases on mortality and carcass
traits. The study group consisted of 3519 white veal
calves, housed in 10 commercial veal farms in Northern
Belgium. Participating herds were conveniently selectedbased upon willingness to cooperate, but independent of
any disease history. In the veal industry the diet differs
in between breeds and therefore calves of the same
breed or confirmation (e.g. crossbreds) are grouped
within a farm. Therefore, a veal production type stands
for the combination of the breed effect and the specific
diet that breed receives. In the present study the sample
was stratified on production type (3 dairy, 4 beef and 3
crossbred herds). Dairy calves belonged to the black or
red Holstein Friesian (BHF and RHF) breed, beef calves
were mostly Belgian Blue (BB) and crossbreds mainly in-
volved HFxBB. Selected herds belonged to six different
integrations, including the three largest integrations in
Belgium. An integration is a company that combines all
steps of the production chain by having its own feed
plant and slaughterhouse and by placing its calves in
veal herds owned by producers that fatten these calves
for the integration on contract. One all in/all out pro-
duction cycle per herd (= 1 cohort) was monitored from
calf arrival to slaughter, and all calves from that cohort
were included in the study. Herds gradually entered the
study between January 2008 and October 2009. Calves
originated from multiple herds and were transported
within 24 h from the herd of origin to the veal herds, at
the minimum age of 14 days old, after a short stay at a
sorting center. Calves were individually housed during the
first 6 weeks and thereafter group housed in galvanized
pens on slatted floors in compliance with European legis-
lation (Council Directives 91/629/EEC and 97/2/EC).
Calves received an all-liquid milk diet, supplemented with
solid feed (fibers and concentrates according to European
legislation). The milk diet was different between the three
production systems: beef calves received predominantly a
high quality skimmed milk powder, whereas the skimmed
milk diet of dairy and crossbred calves was progressively
changed to a lower quality milk powder, based on whey
and vegetable proteins, in 8 weeks’ time. Calves were not
vaccinated against any pathogen.
Data collection
Calves were individually identified by ear tag, according to
Belgian law. Calf entry characteristics (birth date, arrival
date, breed, gender) were collected from the Belgian cattle
registration system (SANITEL). The date of mortality and
the cause as determined by necropsy were recorded. The
used definitions for each cause of death were as published
previously [17]. All individual (calf identity, indication and
drug) and group treatments, administered by producer or
veterinarian, were recorded daily on written treatment re-
cords. Clinical signs on which the producers based their
decision to individually treat an animal were the presence
of liquid feces for diarrhea, swollen joints and/or lameness
for arthritis and head tilt for otitis. For respiratory disease
producers used mental state, appetite, nasal discharge,
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dyspnea as criteria. Herds were visited by the primary
investigator between 4 and 8 times during the registration
period to check compliance with the recording system.
Slaughter data (date of slaughter, hot carcass weight
(HCW), carcass quality, color and fat classification) were
collected at the slaughter houses. The European SEUROP
classification system was used to determine carcass quality
(18 classes) and scoring was done visually by trained staff.
Meat color was determined by spectrophotometry and the
European classification system was used (10 classes) [26].
Serology
Given the diverse etiology of BRD in calves, paired ser-
ology was used to identify the circulating pathogens. In
each herd 25 calves were randomly selected at arrival
using the official stable lists. Blood samples, taken within
the normal management practices in veal production
(determination of iron levels) at arrival and 24 weeks
later, were used. Serum was collected within 8 hours
after sampling and stored at −18°C until analysis. Semi-
quantitative indirect ELISA’s were used to detect anti-
bodies (IgG1) against bovine respiratory syncytial virus
(BRSV), parainfluenza virus type 3 (PI-3), bovine viral
diarrhea virus (BVDV) (NS2-3 native protein), bovine
adenovirus type 3 (BAV-3), BHV-1 (Respiratory ELISA
kit pentakit, Bio-X Diagnostics, Jemelle, Belgium) and
Mycoplasma bovis (M. bovis ELISA kit, Bio-X). Tests
were performed and interpreted according to the manu-
facturers prescriptions, as outlined in detail elsewhere
[27]. Sera from the same calf were tested on the same
plate. Antibodies against Mannheimia haemolytica (whole
cell) were determined at the laboratory of MSD Animal
Health (Boxmeer, The Netherlands) with an in-house
ELISA [28]. Dilution series of the sera were incubated on
plates and bound antibodies were detected after incuba-
tion with an anti-bovine serum-peroxidase conjugate [28].
A four-fold titer increase was considered a seroconversion.
All methods used in this study were in concordance with
the ethical conditions for animal experimentation as men-
tioned in the Belgian (KB 14 August 1986) and European
legislation (Directive 86/609/EEC).
Data management
Mortality, treatment and slaughter data were entered in a
relational data base (Access 2007, Microsoft Inc.) and trans-
ferred to SAS version 9.3 (SAS Institute Inc., Cary, NC) for
descriptive and statistical analysis. A calf was considered a
case of a given disease (respiratory disease, diarrhea, otitis
and arthritis), when individually diagnosed and treated by
the producer or veterinarian for that indication on at least
one day. For respiratory disease, a calf could experience
several episodes. Each newly started treatment course more
than 14 days after the preceding treatment, was counted asa new episode [17,29]. A relapse case is defined as an
animal, which experienced 2 or more BRD episodes. The
long acting effect of certain antimicrobial formulations
was taken into account by counting one injection as 2
(tilmicosin, amoxicillin, florfenicol, danofloxacin) or 9
(tulathromycin) days of treatment [17,29]. The mortality
risk was calculated as the number of death calves divided
by the number of calves at risk at calf arrival [17]. The di-
rectors of the slaughterhouses were asked which SEUROP
score of fat cover, carcass quality and carcass color they
judged as insufficient for white veal production. Based on
this judgment, binary outcome variables were constructed
for these variables. Fat cover was split into carcasses
with no fat (European class 1) and normal to extremely
fat carcasses (European class 2 to 5). All carcasses
graded P + (European class 13) and lower were grouped
as insufficient carcass quality and analyzed as such. For
meat color two classes were created, representing white
meat (European class 1 to 6) and meat with an undesir-
able red color (European class 7 to 10) for white veal
production. Hot carcass weight (HCW) (kg) was mea-
sured at the slaughterhouse at 0.1 kg precise. Drug use
was determined according to standard daily dose meth-
odology [24]. For modeling purposes, the percentage of
the production cycle that calves spent on oral anti-
microbial drugs (= antimicrobial drug use (ADU)) was
calculated for each individual calf. ADU was calculated
as the number of days spent on oral antimicrobials/
total number of days on feed (DOF) x 100. DOF was
calculated on an individual basis by subtracting the ar-
rival date from the slaughter date.
In order to estimate the economic consequences of
the observed disease effects, the average prices per kg
HCW from years 2008–2009, available from the veal in-
dustry, were used. These were 4.6 €/kg (standard devi-
ation (SD) = 0.5) for BHF, 5.3 €/kg (SD = 1.0) for RHF,
6.4 €/kg (SD = 1.0) for crossbreds and 8.1 €/kg (SD = 0.8)
for BB. Meat with an undesirable red color returned 0.1
€/kg, 0.2 €/kg, 0.4 €/kg and 0.2 €/kg less compared to an
adequate pale color of the carcass for BHF, RHF, cross-
breds and BB, respectively. Carcasses with a European
fat grading score of 1 (very skinny) returned 0.1 €/kg,
0.2 €/kg, 0.0 €/kg for BHF, RHF and crossbreds, respect-
ively. In contrast BB carcasses with a fatness degree of 1
returned 0.4 €/kg more. Carcasses with a SEUROP score
of 13 or less returned 0.1 €/kg, 0.3 €/kg, 1.7 €/kg and 0.3
€/kg less compared to higher scores, for BHF, RHF,
crossbreds and BB, respectively. The total treatment cost
per calf (in €) included the costs related to both group
and individual treatments. The cost of oral group treat-
ments was calculated for each herd from the official
treatment records, which are under supervision of the
federal agency responsible for safety of the food chain,
using the average price (€/kg product) of each drug from
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practices who sold these products. The cost of individual
treatment for each calf was calculated by multiplying the
number of individual treatment days by the average cost
of one individual treatment day. An individual treatment
day was defined as each day on which an individual calf
received one or more individual treatments. The cost of
an individual treatment day was calculated by dividing the
cost of all individually administered drugs in a herd by the
total number of individual treatment days for that herd.
Feed cost, labor, housing costs and governmental supports
were not taken into account for cost calculation.
Statistical analysis
The unit of analysis was the individual calf. To estimate
the effect of the studied diseases (BRD, diarrhea, arthritis
and otitis) on HCW a linear mixed model with herd as
random factor to account for clustering of calves within a
herd was used (PROC MIXED). First the continuous out-
come variable (HCW) was checked for a normal distribu-
tion. Univariable associations between predictor variables
(BRD, diarrhea, otitis, arthritis, age at arrival, breed, gen-
der and ADU) were explored by univariable logistic
(PROC GLIMMIX) regression for binary outcomes and by
ANOVA for continuous variables (PROC MIXED). Next
all predictor (studied diseases, breed, age at arrival, gender
and ADU) variables were tested univariably for their asso-
ciation with HCW. All predictors with P < 0.2 in the
univariable model were maintained for the multivariable
model, which was built stepwise backward, gradually ex-
cluding non-significant variables. Before entering the pre-
dictor variables in the multivariable model Pearson and
Spearman’s rho correlations were calculated and when
correlation was higher than 0.60, only the most significant
variable was retained. For the final models, pairwise com-
parisons for categorical predictors were made, with
Bonferroni adjustment for multiple comparisons. All bio-
logically relevant two-way interactions of significant fixed
effects were tested. Significance was set at P < 0.05 and P
< 0.10 was considered a trend. When necessary to make
the models convert, otitis and arthritis were combined
into one variable. Model fit and assumptions were evalu-
ated by (graphically) checking the normal distribution of
the residuals.
The effect of the different calf diseases on low fat
cover (0/1), red meat color (0/1), and low carcass quality
(0/1) was analyzed by multivariable logistic regression. A
generalized linear mixed model (PROC GLIMMIX) was
used with binomial distribution and logit link function
with Wald’s statistics for type 3 contrasts. Herd was
added as a random factor to account for clustering. First,
the same predictors as for the mixed model, were tested
univariably. All predictors with P < 0.2 in the univariable
model were maintained for the multivariable model,which was built stepwise backward, gradually excluding
non-significant variables. For the final models, pairwise
comparisons for categorical predictors were made, with
Bonferroni adjustment for multiple comparisons. All
biologically relevant two-way interactions of significant
fixed effects were tested. Significance was set at P < 0.05
and P < 0.10 was considered a trend. When necessary to
make the models convert, otitis and arthritis were com-
bined into one variable. Model fit was evaluated by the
Hosmer-Lemeshow goodness-of-fit test for logistic
models [30].
To visualize the relationship between the studied dis-
ease and mortality over time, first Kaplan-Meier survival
curves (PROC LIFETEST) were created, disregarding
the fact that there might be a dependence of the herd. In
a next step a multivariable Cox proportional hazards
model (PROC PHREG) was built, with a frailty term to
account for clustering of calves within a herd. DOF
(days) was used as the survival time and mortality (0/1)
as the censor variable. Right censoring occurred at the
date of slaughter. Exposures considered were BRD, diar-
rhea, arthritis, otitis, age at arrival, breed and gender.
First all predictors were tested univariably, and those
with P < 0.20 were withhold for the multivariable model.
This model was built stepwise backwards, gradually ex-
cluding none-significant variables. All biologically rele-
vant two-way interactions of significant fixed effects
were tested. Significance was set at P < 0.05 and P < 0.10
was considered a trend. Wald’s test was used to assess
parameter estimate significance. Visual inspection of the
log-cumulative hazard plots and the Schoenfeld residuals
was used to evaluate compliance with the assumptions
of proportional hazard models [30]. Because the disease
risk varies over time, the assumption of proportional
hazards is likely violated. Therefore, a second approach
was made adding the diseases as time-varying covariates
instead of fixed factors. The same model building strat-
egy as for the model with fixed factors was used.
Results
Animals and serology
Mean size of the studied cohorts was 351.9 calves (SD =
121.6; Range (R) = 166–570). Of the 3519 veal calves, 36.8%
was BHF, 3.5% RHF, 34.5% BB and 25.1% crossbreds.
The majority of the calves was male (91.0%; 3202/3519).
The proportion of females was higher in red HF (13.7%;
17/124), BB (9.1%; 111/1215) and crossbreds (16.4%; 145/
884) than in black HF (3.4%; 44/1296) (P < 0.001). The
mean age at arrival was 18 days (SD = 4.8; R = 4–41). Of
the calves, 4.1% was of non-Belgian origin and these were
exclusively dairy calves. The Belgian calves originated from
multiple herds with an average of 1.3 (SD = 0.1; R = 1.2-1.5)
delivered calves per herd of origin. The mean time spent in
production (DOF) was 192.0 days (SD = 33.5; R = 0–281),
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(196.0; SD = 37.6) than in red (180.7; SD = 47.0) or black
HF (186.2; SD = 27.2) (P < 0.001). M. bovis, BVDV and
BAV-3 were the most prevalent pathogens in the studied
cohorts (Table 1).
Morbidity and mortality
Based on standard daily dose methodology, the average
treatment incidence was 407.8 animal daily dosages per
1000 calves at risk [24]. This means that the studied
calves received enough oral antimicrobials to treat them
for 41,4% of the production cycle length. However, in
reality, due to the frequent combination of multiple anti-
microbials into one oral treatment, calves received anti-
microbials in the milk for on average 25.2% (SD = 10.0;
Range (R) = 10.3-45.0) of the time (=ADU). Further de-
tails on drug use are available elsewhere [24]. In addition
to the metaphylactic group treatments, 22.7% (798/3519)
of the calves was individually treated for one or more
diseases. Of the calves, 14.8% (522/3519) were individu-
ally diagnosed and treated for BRD, 5.3% (186/3519) for
diarrhea, 1.5% (52/3519) for arthritis and 1.6% (56/3519)
for otitis. The average BRD incidence at the cohort level
was 17.2%, ranging from 8.2-33.9%. Of the calves, 1.7%
(59/3519) experienced 2 BRD episodes and 0.3% (12/3519)
3 or more episodes. The average day of first treatment
for BRD, diarrhea, arthritis and otitis was 41.2 (SD = 39;
Median (M) = 27.5; R = 1–287), 12.2 (SD = 27.1; M = 6;
R = 1–273), 56.5 (SD = 174; Median = 43; R = 2–174) and
63.0 (SD = 43.2; M = 55; R = 3–231) days after arrival,
respectively. Older calves at arrival had less risk to develop
diarrhea (odds ratio (OR) = 0.95 per day increase in
age; 95% confidence interval (CI) = 0.91-0.98; P < 0.01),
whereas neither age at arrival, gender or breed influenced
the occurrence of BRD, otitis and arthritis. Calves with
diarrhea had higher risks for BRD (OR = 2.8; CI = 2.0-3.9;
P < 0.001) and BRD was associated with increased risks to
develop arthritis (OR = 2.2 ; CI = 1.2-4.2; P < 0.05) and oti-
tis (OR = 2.4; CI = 1.3-4.2; P < 0.01).
The number of individual treatment days was on aver-
age 5.6 days (SD = 5.9) per treated calf, ranging from 1
to 46. The mean cost of individual treatment in theseTable 1 Seroconversion riska for respiratory pathogens in 10
Pathogen Seroconversion risk (%) (mea
Bovine respiratory syncytial virus 8.4 ± 11.4
Parainfluenzavirus type 3 21.2 ± 9.8
Bovine viral diarrhea virus 57.6 ± 27.1
Bovine herpesvirus type 1 3.2 ± 5.9
Bovine adenovirus type 3 50.8 ± 17.1
Mycoplasma bovis 79.6 ± 13.7
Mannheimia haemolytica 32.4 ± 26.4
aSeroconversion risk = number of animals within a cohort that seroconverted/total nindividually treated calves was €50.9 (SD = 51.1; M =
33.8; R = 8.5-270.4). The mean cost of the oral group
treatments was €7.5 (SD = 3.8; R = 2.8-13.5). Descriptives
of all outcome variables are given by disease in Table 2.
Overall, 5.7% (199/3519) of the calves died before the
end of the production cycle, of which 27.1% (54/199)
was classified as pneumonia, 7.5% (15/199) as enteritis
and 3.5% (7/199) as arthritis. Other important causes of
death were acute ruminal disorders (11.0%), enterotox-
aemia (10.0%), idiopathic peritonitis (7.0%), death at ar-
rival (5.0%), omphalitis (2.5%) and perforating abomasal
ulceration (2.5%) (10.0% of the calves was not autop-
sied). No calves died from otitis only. Of the calves, that
died from pneumonia, 66.7% (36/54) had been individu-
ally treated for BRD. Fatal cases of enteritis and arthritis
were individually treated for the respective disease in
40.0% (6/15) and 71.4% (5/7) of the cases, respectively.
In Figure 1, the survival curves for the studied diseases
are shown. In the proportional hazards model with the
diseases added as fixed factors, all diseases, except
for otitis, were associated with a higher mortality risk
(P < 0.001) (Table 3). The mortality risk markedly increased
with increasing number of BRD episodes (P < 0.001). When
adding the studied diseases as time-varying covariates two
important changes were noted (Table 4): otitis became sig-
nificantly associated with mortality and the hazard ratio for
diarrhea markedly increased (from 2.8 to 11). In both
models female calves were less likely to die (P < 0.03) and
red HF showed a higher mortality risk compared to all
other breeds (P < 0.03) (Tables 3 and 4).
Carcass traits
HCW was available for 3210 calves. The remaining
calves died during production (n = 199) or were live
exported (n = 110). The mean HCW was 171.0 kg (SD =
33.2) ranging from 61.0 to 277.3 kg (red HF = 148.9 (SD
= 20.1); Black HF = 152.0 (SD = 24.1); Crossbreds = 176.1
(SD = 27.7); BB = 194.1 (SD = 32.1)). Of the variation in
HCW, 48% was situated at herd level and 52% at the in-
dividual calf level. In a first model all diseases were
added separately, not taking the number of BRD epi-
sodes into account (Table 5). Breed, gender and ADUwhite veal cohorts in Belgium, 2008-2009








umber of calves present in that cohort x 100; SD = standard deviation.
Table 2 Mortality and carcass traits by disease history in 3519 white veal calves, housed in 10 Belgian herds, 2008-
2009
Disease Level Calves (n) Mortality HCW (kg) Mean ± SD Low fat covera Red meat colorb Low carcass qualityc
% (number) (min.-max.) % (number) % (number) % (number)
Number of
BRD episodes
None 2997 4.3% (128/2997) 172.6 ± 33.0 (61.0-277.3) 6.1% (160/2629) 14.7% (386/2629) 10.3% (272/2637)
1 451 12.0% (54/451) 163.3 ± 30.6 (79.8-246.2) 10.6% (39/367) 15.0% (55/367) 7.8% (29/370)
2 59 22.0% (13/59) 142.5 ± 38.2 (81.0-251.0) 10.8% (4/37) 27.0% (10/37) 27.0% (10/37)
≥ 3 12 33.3% (4/12) 137.6 ± 36.5 (93.8-189.0) 28.6% (2/5) 14.3% (1/7) 42.9% (3/7)
Diarrhea No 3333 5.1% (169/3333) 171.3 ± 33.3 (61.0-277.3) 6.7% (196/2907) 15.1% (440/2907) 10.3% (300/2917)
Yes 186 16.1% (30/186) 164.5 ± 30.1 (87.7-244.9) 6.8% (9/133) 9.0% (12/133) 10.4% (14/134)
Otitis No 3463 5.6% (194/3463) 171.4 ± 33.1 (61.0-277.3) 6.9% (205/2992) 15.0% (448/2992) 10.3% (308/3003)
Yes 56 8.9% (5/56) 146.8 ± 27.5 (98.9-246.2) 0.0% (0/48) 8.3% (4/48) 12.5% (6/48)
Arthritis No 3467 5.4% (187/3466) 171.1 ± 33.1 (61.0-277.3) 6.7% (202/3014) 15.0% (452/3014) 10.3% (312/3025)
Yes 52 23.1% (12/52) 167.2 ± 39.2 (65.9-226.7) 11.5% (3/26) 0.0% (0/26) 7.7% (2/26)
HCW = hot carcass weight; SD = standard deviation; BRD = bovine respiratory disease; aEuropean SEUROP class 1 regarded as insufficient fat cover; bEuropean
SEUROP class 7 to 10 regarded as undesirable red meat color; cEuropean SEUROP class 13 (P+) and lower.
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crease of ADU by 1%, HCW reduced by 1.5 kg on aver-
age. BRD and diarrhea (P < 0.001) were associated with
marked weight loss, respectively 9.7 kg and 9.2 kg. In
this model the interactions between arthritis and BRD
(P < 0.01) and arthritis and otitis (P = 0.01) were signifi-
cant. HCW of arthritis cases only differed significantly
from apparently healthy calves when also treated for
BRD. The second interaction was situated in the fact
that only arthritis cases, which did not have otitis, dif-
fered significantly from the control group. Otitis as such
was not associated with a reduced slaughter weight. The
three way interaction between BRD, arthritis and otitis
did not converge. The final model as shown in Table 5
explained 6.0% and 15.4% of the variation in HCW at
calf and herd level, respectively. A second model was
made in order to assess the effect of the number of BRD
episodes on HCW, using a combining variable for otitis
and arthritis to make the model converge. HCW de-
creased severely with increasing number of BRD epi-
sodes, namely with on average 8.2 kg, 22.4 kg and
41.6 kg in calves, which experienced 1, 2 or ≥3 BRD epi-
sodes, respectively (P < 0.001) (Table 6). This model
showed a slightly better fit and explained 6.0% and 9.0%
of the variation at calf and herd level, respectively.
Meat color was available for 3040 calves. The odds
for an undesirable red meat color trended to be larger in
calves, which relapsed for BRD (≥2 episodes) (OR = 2.5;
CI = 1.0-6.4; P = 0.06) and increased with increasing
age (OR = 1.04 per day increase in age; CI = 1.01-1.06;
P < 0.01). In contrast, the combining variable of arthritis
and otitis was associated with a lower risk (OR = 0.25;
CI = 0.09-0.71; P < 0.01). With an increasing percentage
of the production time spent on oral antimicrobials
(=ADU), the odds for too red meat decreased (OR = 0.86per percentage increase in ADU; CI = 0.76-0.98; P < 0.05).
Also, female calves trended to have a higher odds for red
meat color (OR = 1.4; CI = 0.9-2.1; P = 0.10). Fat cover
(available for 3040 calves) was only affected by BRD, with
calves treated once (OR = 2.5; CI = 1.5-4.2; P < 0.001) and
relapse cases (OR = 3.8; CI = 1.0-15.1; P = 0.06) being more
likely to have carcasses with too low fat cover. Also, with
an increasing percentage of the production time spent on
oral antimicrobials (=ADU), the odds for insufficient fat
cover decreased (OR = 0.88 per percentage increase in
ADU; CI = 0.78-0.99; P < 0.05). Carcass quality was avail-
able for 3051 calves. Calves which experienced diarrhea
(OR = 2.5; CI = 1.2-5.4; P < 0.05) or relapsed for BRD (two
episodes vs. none (OR = 10.9; CI = 3.1-38.5; P < 0.001) and
three or more episodes vs. none (OR = 50.0; CI = 3.6-
333.3; P < 0.001)) had higher odds for low carcass quality
(SEUROP score P + or lower). Also, BB calves had lower
odds (OR = 0.07; CI = 0.01-0.42; P < 0.001) for low carcass
quality compared to red HF.
Economic considerations
From the regression models and based on the average
prices from 2008–2009, as provided in this article, esti-
mations of the economic consequences of the studied
diseases could be made. For example, in calves which ex-
perienced 1 BRD episode the average loss in HCW of
8 kg signifies a financial loss of €36.8, €42.4, €51.2 and
€64.8 in BHF, RHF, crossbreds or BB calves, respectively.
In a BHF veal calf, which experienced three BRD epi-
sodes, on average 41.6 kg of carcass weight is lost,
representing €187.2. This calf also has higher odds for
low carcass quality and too red meat color. When tak-
ing into account that this calf weighs on average
110.4 kg (41.6 kg less than the average BHF calf ), an
additional loss of €11.4 for low carcass quality and also
Figure 1 Survival distribution functions for mortality in 10 commercial veal herds in Belgium, including calves (n = 3519) individually
diagnosed and treated for bovine respiratory disease (A), diarrhea (B), arthritis (C) and otitis (D).
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brings the total loss to €210, to which the costs of
group and individual antimicrobial treatment still need
to be added. For comparison, in BB calves, which have
a much higher meat price due to the excellent carcass
characteristics, the same calf would signify a financial
loss as high as €622.3.Discussion
The present study aimed at determining the long term
effect of different calf diseases on important economic
parameters in white veal production. Unfortunately, nu-
trition, which is known to explain the greatest propor-
tion of variation in HCW, could not be included in the
models [31,32]. The reasons were that the different
Table 3 Proportional hazard model for mortality in 3519 white veal calves, housed in 10 commercial veal herds in
Belgium with the studied diseases added as fixed factors
Variable Level Calves (n) ß SD HR HR (95% CI) P-value
Calf gender Male (ref) 3202 0 -
Female 317 −0.8 0.4 0.4 0.2-0.9 0.04
Breed 0.04
Black HF (ref.) 1296 0 -
Red HF 124 0.7 0.3 2.1 1.1-5.5 0.03
Crossbreds 884 −0.2 0.3 0.8 0.5-1.4 0.44
BB 1215 −0.3 0.3 0.7 0.4-1.4 0.33
Number of BRD episodes <0.001
None (ref.) 2997 0 -
1 451 1.0 0.2 2.6 1.9-3.6 <0.001
2 59 1.4 0.3 4.1 2.2-7.8 <0.001
≥ 3 12 1.9 0.5 6.5 2.5-16.5 <0.001
Diarrhea No (ref.) 3333 0 -
Yes 186 1.0 0.2 2.8 1.9-4.2 <0.001
Arthritis No (ref.) 3467 0 -
Yes 52 1.1 0.3 2.9 1.6-5.3 <0.001
Herd effect a 0.3 0.2 <0.001
SD = standard deviation; HR = hazard ratio; BRD = bovine respiratory disease; HF = Holstein Friesian; BB = Belgian Blue; ref. = referent category; afrailty term.
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of the diet and that the commercial veal stables were not
adapted to measure feed intake individually. Neverthe-
less, the present study shows that the studied diseases,
breed and gender explain a substantial proportion of the
variation in HCW at calf and herd level.Table 4 Proportional hazard model for mortality in 3519 whi
Belgium with the studied diseases added as time-varying cov
Variable Level Calves (n) ß
Calf gender Male (ref) 3202 0
Female 317 −0.8
Breed
Black HF (ref.) 1296 0
Red HF 124 0.8
Crossbreds 884 −0.2
BB 1215 −0.3
BRD No (ref.) 2997 0
Yes 522 1.7
Diarrhea No (ref.) 3333 0
Yes 186 2.4
Arthritis No (ref.) 3467 0
Yes 52 1.7
Otitis No (ref.) 3463 0
Yes 56 1.9
Herd effect a 0.3
SD = standard deviation; HR = hazard ratio; BRD = bovine respiratory disease; HF = HAs in most epidemiological studies on BRD, producer
based diagnosis was used, because this approach is clos-
est to realistic on farm procedures and therefore better
interpretable by the industry itself [3,4,9,10,33-35]. For
diarrhea, arthritis and otitis, straightforward case defini-
tions based on obvious symptoms were provided to thete veal calves, housed in 10 commercial veal herds in
ariates
SD HR HR (95% CI) P-value
-
0.4 0.5 0.2-0.9 0.04
0.05
-
0.3 2.1 1.1-4.2 0.03
0.3 0.8 0.5-1.4 0.50
0.3 0.8 0.4-1.4 0.38
-
0.3 5.5 3.0-10.2 <0.001
-
0.4 11.0 5.4-22.6 <0.001
-
0.9 3.9 1.6-5.3 0.05
-
0.9 7.0 1.3-38.5 0.03
0.2 <0.001
olstein Friesian; BB = Belgian Blue; ref. = referent category; afrailty term.
Table 5 Final linear mixed model with pairwise
comparisons for the effect of the most frequent calf
diseases on hot carcass weight (HCW) (kg) of 3210 white
veal calves, housed in 10 herds in Belgium, 2008-2009
Variable Level Reference ß SD P-value
Breed < 0.001
Red HF Black HF −4.5 2.4 0.36
Crossbreds Black HF 3.1 1.7 0.42
BB Black HF 10.4 2.1 <0.001
Crossbreds Red HF 7.6 2.5 0.02
BB Red HF 15.0 2.8 <0.001
Crossbreds BB 7.3 1.5 <0.001
ADU (%) −1.5 0.4 < 0.001
Calf gender Female Male −10.2 1.6 <0.001
Diarrhea Yes No −9.2 2.0 <0.001
BRD Yes No −39.8 10.4 <0.001
Arthritis Yes No 7.7 16.9 0.65
Otitis Yes No 39.8 19.0 <0.01
BRD x ART <0.01
No BRD/ART No BRD/No ART 14.3 10.6 1.0
BRD/No ART No BRD/No ART −9.7 1.3 <0.001
BRD/ART No BRD/No ART −25.6 9.7 0.05
BRD/No ART No BRD/ART −24.0 10.6 0.15
BRD/ART No BRD/ART −39.8 10.4 <0.001
BRD/ART BRD/No ART −15.9 9.8 0.62
OTI x ART 0.01
No OTI/ ART No OTI/No ART −24.4 5.3 <0.001
OTI/No ART No OTI/No ART −7.4 3.5 0.21
OTI/ART No OTI/No ART 15.4 17.3 1.0
OTI/No ART No OTI/ART 17.1 6.3 0.04
OTI/ART No OTI/ART 39.8 19.0 0.22
OTI/ART OTI/No ART 22.8 17.6 1.0
SD = standard deviation; BB = Belgian Blue; HF = Holstein Friesian;
ADU = antimicrobial drug use expressed as the number of days on oral
antimicrobials/total number of days on feed (%); BRD = bovine respiratory
disease; ART = arthritis; OTI = otitis; x = interaction.
Table 6 Final linear mixed model with pairwise
comparisons for the effect of the number respiratory
disease episodes and other diseases on hot carcass
weight (HCW) (kg) in 3210 white veal calves, housed in
10 herds in Belgium, 2008-2009
Variable Level Reference ß SD P-value
Breed <0.001
Red HF Black HF −4.4 2.4 0.4
Crossbreds Black HF 3.0 1.8 0.48
BB Black HF 10.4 2.1 < 0.001
Crossbreds Red HF 7.4 2.5 0.02
BB Red HF 14.8 3.0 < 0.001
Crossbreds BB 7.4 1.5 <0.001
ADU (%) −1.6 0.4 <0.001
Calf gender Female Male −10.2 1.6 <0.001
Diarrhea Yes No −9.2 2.0 < 0.001
ART and/or OTI Yes No −9.1 2.6 < 0.001
BRD < 0.001
1 episode No BRD −8.2 1.3 <0.001
2 episodes No BRD −22.4 3.8 <0.001
≥3 episodes No BRD −41.6 8.3 < 0.001
2 episodes 1 episode −14.2 3.9 < 0.001
≥3 episodes 1 episode −33.4 8.4 <0.001
≥3 episodes 2 episodes −19.3 9.1 0.20
SD = standard deviation; BB = Belgian Blue; HF = Holstein Friesian;
ADU = antimicrobial drug use expressed as the number of days on oral
antimicrobials/total number of days on feed (%); BRD = bovine respiratory
disease; ART and/or OTI = combining variable for calves treated for arthritis
(ART) and/or otitis (OTI).
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for these diseases. For BRD the situation is more compli-
cated, as it is well known that based on clinical examin-
ation both farmers as veterinarians tend to detect only a
proportion of the cases and rather late in the disease
process [36,37]. Especially the initial symptoms of an in-
fection with M. bovis, the dominant pathogen in the veal
industry, are very subtle, even when extensive pneumo-
nia is already present, and hard to evaluate in individual
housing [38]. An additional issue in the veal industry is
the frequent use of pro- and metaphylactic antimicrobial
group treatment, which interferes with the recognition
of individual disease [39]. Also, in the present study, onethird of the calves, which showed extensive pneumonia at
necropsy, has not been individually diagnosed previously.
For these reasons and despite that the BRD incidence was
in line with what has been reported for feedlots (17.0% on
average, ranging from 4.6-43.8%) and even higher than
reported in veal calves in the Netherlands, Italy and France
(<7%), the BRD incidence is likely underestimated in the
present study [5,39]. Therefore, the results and associa-
tions documented in this study should be interpreted as
representing animals with obvious clinical symptoms, with
onset of BRD before the installment of the metaphylactic
group treatment or calves non-responding to oral group
treatment. The overall economic loss due to BRD is likely
greater than demonstrated in the present study.
When looking at the short term consequences of BRD,
significant weight loss in the three weeks following dis-
ease has been demonstrated both in feedlot cattle
(−0.370 kg/day) and veal calves (−0.070 kg/day to
−0.280 kg/day depending on the installed treatment)
[16,23]. When analyzed over the complete production
cycle the loss in average daily gain (ADG) is less pro-
nounced (e.g. -0.070 kg/day in feedlots), signifying that
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sequent compensatory weight gain occurred in treated
animals, possibly because BRD cases show a higher eat-
ing frequency after disease [23,40]. In South African
feedlots this weight loss was shown to be fully compen-
sated, but in most other feedlot studies a significant re-
duction in HCW or ADG was still present at slaughter
[6,13,23]. Also in the present study a single BRD episode
reduced HCW by 8.2 kg on average, which is similar to
feedlot cattle [6,23]. However, the relative loss in HCW
is higher in white veal calves compared to feedlot cattle
(4.9% vs. 2.3%) and has a greater economic significance,
because of the higher prices for veal meat [6]. This BRD
associated weight loss has been attributed to reduced
feed intake due to anorexia and depression and to the
increased protein and caloric cost of a febrile response
and (chronic) inflammation [40-44].
As in feedlots and dairy calves, also in veal calves the re-
duction in HCW became more pronounced with an in-
creasing number of BRD episodes [6,8,10,23,45]. Chronic
BRD also had a significant negative effect on carcass qual-
ity and fat cover, as documented for feedlots [6,9]. In feed-
lots chronic unresponsive pneumonia has been associated
with Mycoplasma bovis and bovine viral diarrhea virus
[46,47]. Both pathogens were also highly prevalent in the
studied herds as documented previously in white veal
calves [27,48]. In addition to pneumonia, M. bovis causes
arthritis and otitis media (M. bovis associated disease
(MbAD)) [46]. The effects of arthritis on performance
have not been specifically reported, despite the high inci-
dence of MbAD in feedlots. In the present study calves
with concurrent arthritis and BRD showed extensive
weight loss similar to chronic BRD cases, whereas calves
with only arthritis did not have a significant lower HCW.
Most likely in the latter calves the arthritis was of trau-
matic origin and healed after treatment, whereas it was as-
sociated with chronic M. bovis infection in the calves with
concurrent BRD. In calves with chronic arthritis feed up-
take is likely further reduced, since the painful joints make
them reluctant to move to the drinking trough to eat. Oti-
tis media was not associated with decreased growth, as
was the case in a dairy heifer raising facility with high inci-
dence of M. bovis [12]. Whether this truly means that oti-
tis does not affect performance, or whether the individual
antimicrobial treatment has been installed quickly enough
by the producers due to the obvious clinical symptoms,
hereby alleviating the negative consequences, remains to
be determined. When adding otitis as a fixed variable to
the survival model, no association with mortality could be
demonstrated, as was the case in a previous study on dairy
heifers with otitis [12]. In contrast, when working with oti-
tis as a time-varying covariate, a significant effect of otitis
on mortality was found. This is related to the fact that an
animal that gets otitis has a higher hazard of dying withinthe 7 days after the infection than in the rest of the at risk
period. However, given the relatively low number of events
for otitis and arthritis, these findings should be interpreted
carefully. Mortality, especially at older age, greatly deter-
mines the economic revenues of a group of veal calves.
The present study shows that all studied diseases have an
important association with this mortality risk. Given that
M. bovis is associated with BRD, arthritis and otitis, pre-
ventive and curative management of this pathogen should
have priority. Also, the mortality risk of both chronic BRD
and arthritis cases was increased in such a way, that one
should question whether treatment of a 3rd BRD episode
or arthritis is still economically and ethically justifiable.
In contrast to BRD, few studies have addressed the ef-
fects of neonatal calf diarrhea on survival and carcass
traits. Diarrhea increased the mortality risk in white veal
calves as has been observed in conventional dairy calves in
the first 180 days of life [49]. The present study also
showed that developing diarrhea, which occurs predomin-
antly in the first 3 weeks after arrival, has a markedly
stronger association with mortality than BRD, arthritis or
otitis in veal calves. Therefore, management of this disease
deserves full attention in veal herds. Further work to clar-
ify which diarrhea pathogens are exactly associated with
the highest mortality risk and to identify risk factors for
diarrhea is needed in order to be able to install effective
control measures. Previously, in veal calves, diarrhea has
been associated with significant weight loss in the clinical
period [14]. Additionally, the present study shows a sig-
nificant long term effect of diarrhea on HCW value in veal
calves, similar to effects observed in large scale dairy calf
rearing (−0.051 kg/day) in the same age period [50].
Whereas in one study in small scale dairy calf rearing full
compensation of neonatal diarrhea associated weight loss
at the age of 3 months was reported, the present and a
previous study in large scale dairy calf rearing demon-
strated that weight loss due to neonatal diarrhea is not
fully compensated at the age of 6 months [10,50]. It is
important to notice that diarrhea also influenced carcass
grading, causing additional economic loss. Despite the
fact that calves, which had developed diarrhea, were
predisposed for BRD, as was seen in other studies, the
interaction between BRD and diarrhea was not significant
in any model, suggesting that both diseases independently
significantly affected HCW [51,52].
Meat color is an important marketing parameter,
which greatly determines carcass value in white veal
calves [1]. The white color of veal meat is obtained by
reducing iron uptake, resulting in lower hemoglobin
(Hb) and myoglobin levels. However, meat color is
affected by much more factors, since Hb only accounted
for 29% of the variation in visual color score [53]. In the
present study, a trend was shown that chronic BRD
results in an increased probability of undesirable red
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fact that chronic stress causes dark, firm and dry meat,
might be that chronic BRD cases, which often suffer
from ruminal drinking as well, are more frequently
switched to an alternative, more iron rich, concentrate
diet [54]. Other factors associated with red meat were
older age at arrival and female gender. Both effects are
not straightforward to explain, but possibly they are re-
lated to age and gender differences in iron metabolism
as demonstrated in humans and rats [55,56]. In the
present study we were obliged to use a combining vari-
able for otitis and arthritis to make the model for meat
color convert. To fully understand the influence of BRD,
otitis and arthritis on meat color, a dataset large enough
to test the interaction between these diseases is neces-
sary and present results on arthritis and otitis should be
interpreted with care concerning meat color.
One of the most surprising findings in the present study
was that an increase in the percentage of the production
cycle calves spent on oral antimicrobials was associated
with a decrease in HCW. The opposite was to be
suspected, since the growth promoting effect of oral anti-
microbials is well documented [57-59]. Since 2006, anti-
microbial growth promoters are forbidden in Europe (EC
1831/2003), but the trend is that they have at least partly
been replaced by an increased use of therapeutic antimi-
crobials [60,61]. The most likely explanation for the
observed negative association between HCW and anti-
microbial use, is that more antimicrobial group treatments
were used in those herds, which experienced more health
problems. This would mean that the systematic use of oral
antimicrobial group treatments was unable to completely
alleviate the negative consequences of disease on carcass
traits in veal calves. In dairy calves, the use of oral anti-
microbial group treatments in the milk has been associ-
ated with 31% more days with diarrhea in the first 28 days
of life, but not with a difference in ADG [62]. To what ex-
tent oral antimicrobial use in veal calves disturbs the intes-
tinal flora, causing antibiotic-associated diarrhea and
possibly negative effects on performance is currently un-
known. In human medicine, antimicrobial use at young
age in infants from mothers with a normal body weight
has been associated with an increased risk of overweight
at the age of 7 [63]. Possibly, the observed positive associ-
ation between ADU and fat cover in veal calves is due
to similar mechanisms. The effect of in feed antimicrobials
on fat cover and carcass color in veal calves needs to
be further clarified by using more precise and objective
measuring techniques (e.g. measuring fat thickness at
slaughter or by ultrasound [64,65]) than the commonly
used SEUROP classification system as was the case in the
present study.
At present, the high levels of antimicrobial use (espe-
cially oral antimicrobial group treatments) and resistancein the veal industry are of great public concern [24,66-70].
The present study shows that despite numerous anti-
microbial group treatments for BRD and diarrhea, signifi-
cant production loss still occurred in veal calves, which
required individual treatment. Because individual treat-
ment was used as the case definition, this signifies that the
applied individual treatment protocols were unable to
completely alleviate the consequences of disease. One rea-
son might be the enormous infection pressure, inherent to
the production system, which is unable to be completely
overcome by antimicrobial treatment alone. Additional
reasons might be the timing of metaphylaxis, the use of
antimicrobials for which pathogenic bacteria are resistant,
underdosing or insufficiently long individual treatment
courses resulting in relapse or persistent subclinical
pneumonia [17,24,27]. Field studies, evaluating differ-
ent preventive and therapeutic protocols for their abil-
ity to reduce antimicrobial use while maintaining or
even improving current production results, are neces-
sary to direct the veal industry towards the most sus-
tainable production strategy.
Conclusions
Even under the high level of antimicrobial coverage in
contemporary veal production, BRD, diarrhea, arthritis
and otitis increase the mortality risk and all except otitis
have detrimental effects on carcass traits in white veal
calves, leading to substantial economic loss. Losses were
more pronounced in cases of chronic pneumonia with
or without arthritis. Controlling calf health by effective
preventive and therapeutic strategies and in particular
the prevention of chronic BRD is key for the profitability
of veal operations.
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